These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29303148)

  • 1. Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.
    Arsan A; Kanar HS; Sonmez A
    Eye (Lond); 2018 Apr; 32(4):726-733. PubMed ID: 29303148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy.
    Işık MU; Değirmenci MFK; Sağlık A
    Int J Ophthalmol; 2020; 13(9):1404-1410. PubMed ID: 32953579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years.
    Kim YJ; Kim SY; Ha S; Moon D; Seong S; Kwon OW; Park HS
    Eye (Lond); 2019 May; 33(5):819-825. PubMed ID: 30610228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
    Kim JY; Park HS; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
    Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
    Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.
    Malik KJ; Sampat KM; Mansouri A; Steiner JN; Glaser BM
    Retina; 2015 Mar; 35(3):532-6. PubMed ID: 25127050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety.
    Vujosevic S; Martini F; Longhin E; Convento E; Cavarzeran F; Midena E
    Retina; 2015 Aug; 35(8):1594-603. PubMed ID: 25719988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot prospective study of 577-nm yellow subthreshold micropulse laser treatment with two different power settings for acute central serous chorioretinopathy.
    Zhou L; Chong V; Lai K; Huang C; Xu F; Gong Y; Youlidaxi M; Li T; Lu L; Jin C
    Lasers Med Sci; 2019 Sep; 34(7):1345-1351. PubMed ID: 30710172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOW-INTENSITY/HIGH-DENSITY SUBTHRESHOLD DIODE MICROPULSE LASER FOR CENTRAL SEROUS CHORIORETINOPATHY.
    Luttrull JK
    Retina; 2016 Sep; 36(9):1658-63. PubMed ID: 27206160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy.
    Scholz P; Altay L; Fauser S
    Eye (Lond); 2016 Oct; 30(10):1371-1377. PubMed ID: 27391938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.
    Ntomoka CG; Rajesh B; Muriithi GM; Goud A; Chhablani J
    Eye (Lond); 2018 Jun; 32(6):1079-1086. PubMed ID: 29429986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.
    Beniwal A; Shaikh N; Chawla R; Azad SV; Kumar V; Vohra R
    Indian J Ophthalmol; 2022 Sep; 70(9):3341-3345. PubMed ID: 36018117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.
    Koss MJ; Beger I; Koch FH
    Eye (Lond); 2012 Feb; 26(2):307-14. PubMed ID: 22079961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy.
    Shin YI; Kim KM; Lee MW; Kim JY; Jo YJ
    Jpn J Ophthalmol; 2020 Jan; 64(1):28-36. PubMed ID: 31863228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
    Roca JA; Wu L; Fromow-Guerra J; Rodríguez FJ; Berrocal MH; Rojas S; Lima LH; Gallego-Pinazo R; Chhablani J; Arevalo JF; Lozano-Rechy D; Serrano M
    Br J Ophthalmol; 2018 Dec; 102(12):1696-1700. PubMed ID: 29439089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.
    Lee SH; Lee J; Kim M; Roh YJ
    Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1433-1442. PubMed ID: 38010518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in choroidal vascularity in acute central serous chorioretinopathy.
    Rasheed MA; Goud A; Mohamed A; Vupparaboina KK; Chhablani J
    Indian J Ophthalmol; 2018 Apr; 66(4):530-534. PubMed ID: 29582814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.